0001588972false00015889722023-05-172023-05-17

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 17, 2023

 

 

Societal CDMO, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Pennsylvania

001-36329

26-1523233

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1 E. Uwchlan Ave, Suite 112

 

Exton, Pennsylvania

 

19341

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (770) 534-8239

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, par value $0.01

 

SCTL

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 17, 2023, Societal CDMO, Inc. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”). The following is a brief description of the final voting results for each of the proposals submitted to a vote of the shareholders at the Annual Meeting.

Proposal 1 – Election of Class III Directors. Each of William L. Ashton and Laura L. Parks was elected to the Board of Directors as Class III directors to serve until the Company’s 2026 Annual Meeting of Shareholders and until his or her successor, if any, is elected or appointed, or his or her earlier death, resignation, retirement, disqualification or removal as follows:

Name

 

For

 

Withheld

 

Broker Non-Votes

 

William L. Ashton

 

 

39,879,682

 

 

 

14,003,578

 

 

 

12,194,760

 

Laura L. Parks

 

 

42,219,949

 

 

 

11,663,311

 

 

 

12,194,760

 

Proposal 2 – Approval of an Amendment to our Second Amended and Restated Articles of Incorporation, as Amended. The amendment to our Second Amended and Restated Articles of Incorporation, as amended, to increase the number of authorized shares of common stock from 95 million to 185 million was approved as follows:

Votes For

 

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

 

48,187,926

 

 

 

4,700,452

 

 

 

994,882

 

 

 

12,194,760

 

Proposal 3 – Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers. The compensation of the Company’s named executive officers, on an advisory basis was approved, as follows:

Votes For

 

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

 

46,494,706

 

 

 

6,324,853

 

 

 

1,063,701

 

 

 

12,194,760

 

Proposal 4 – Ratification of Independent Registered Public Accountants. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year was ratified as follows:

Votes For

 

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

 

64,575,761

 

 

 

120,511

 

 

 

1,381,748

 

 

 

0

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

SOCIETAL CDMO, Inc.

 

 

 

 

Date:

May 18, 2023

By:

/s/ J. David Enloe, Jr

 

 

 

J. David Enloe, Jr
President and Chief Executive Officer

 
Recro Pharma (NASDAQ:REPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Recro Pharma Charts.
Recro Pharma (NASDAQ:REPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Recro Pharma Charts.